Skip to content
View original post on X: Kevin Weil 🇺🇸
Published
50/100

Warp Sciences launches with $215M Series A to apply AI and robotics to drug development

AIKevin Weil announces Warp Sciences, a new company applying AI and robotics to help develop new medicines faster. Warp raised a $215M Series A led by Lightspeed Venture Partners to bring frontier AI into the lab and build scientific capacity in America.

AIWhy it matters.

The post names the funding amount, lead investor, and founding team, giving context on who is backing a new AI-and-robotics approach to drug development.

Kevin Weil 🇺🇸Verified on X
@kevinweil
View on X

💥 Introducing Warp Sciences, a new company applying AI and robotics to help the world develop new medicines faster.

We’ve raised a $215M Series A led by @lightspeedvp to bring frontier AI out of the browser and into the lab, and build scientific capacity here in America.

I co-founded Warp with my long-time friend @dpatil, FAIR co-founder @manohar_paluri, and drug hunter Sol Reisberg. The early team is full of incredible people like @bkspears9, who helped achieve Q>1 fusion at LLNL.

Source details

Kevin Weil 🇺🇸 · x.comPublished · added here

Original title: 💥 Introducing Warp Sciences, a new company applying AI and robotics to help the world develop new medicines faster.

Topics

Business newsFunding & deals